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Summary: Erythrocyte porphobilinogen synthase deficiency was confirmed by the determination of its activity
in blood and also by the high levels of both porphyrins and 5-aminolaevulinic acid in the urine of two siblings.
jThey presented with a picture of porphyric attack characterized by abdominal colic pain, high blood pressure,
jtachycardia and severe constipation. The profile of both porphyrins and their precursors in urine and blood
•resembled lead poisoning. However, this was mied out because both patients had normal-blood levels of lead.
Furthennore, porphobilinogen synthase activity did not normalize when it was determined in the presence of
dithiothreitol or dithiothreitol plus zinc chloride. No other causes to account for a deficiency in porphobili-
nogen synthase activity were identified.
The simultaneous occurrence of similar clinical and biochemical Symptoms suggests that the same triggering
factor was present. Because the activity of porphobilinogen synthase was less than 4% of normal values, it
is possible that these patients were homozygotes with respect to this defect, which could explain the presence
of clinical Symptoms. We propose that this metabolic defect is not uncommon and it should be kept in mind
when diagnosing of porphyrias or heavy metal intoxications.
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other cases have been descnbed: a child with severe
Porphobilinogen synthase (EC 4.2.1.24; synonym 5- neurologic Symptoms associated to haemolytic anae-
aminolaevulinic acid dehydr(at)ase)1) activity below mia since birth (1) and a man who at 63 presented
50% can be found in up to 2% of the general pop- for the first time a typical acute porphyric crisis (5).
ulation(l). The identification of families with asymp- „,, . .
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-ΑΛ/ i i i * * i control of an autosomic gene with 2 alleles (6) locatedtivity was 25 to 50% below the reference values has . -
 Λ /4λ _. , . . ,_ 0. ' .
.
 J
 t ,. . . . r m chromosome 9 (1). Biochemical (7, 8) and immu-given some clues regarding a genetic transmission of . . ,
 fA m 4 ' . u . . . .6 6
 - - nological (l, 9) studies to charactenze this enzyme
^ ' '' indicate that a mutation of the structural gene could
In 1979, Doss (4) described two young men who be responsible for its Inhibition. The defective gene is
presented with severe Inhibition of erythrocyte por- inherited s an autosomal dominant trait (2, 3),
phobilinogen synthase activity associated to acute whereas the more common kinds of porphyria are
porphyric crisis since adolescence. The pattern of ex- inherited recessively. Acute crises occur in people who
cretion of both porphyrins and their precursors was are homozygous for the defect (7). In these cases, the
similar to a picture of lead poisoning. Since then, two level of porphobilinogen synthase approaches zero.
Heterozygous subjects have enzyme levels in the mid-
- r nge and have no Symptoms.
0
 pS'bilinogen synthase = 5-aminolaevulinic aeid de- Several elements and chemical compounds can inhibit
hydratase (EC 4.2.1.24) a specific enzyme of haem biosynthesis, thereby caus-
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ing a true piclure of porphyria, namely an acquired
Ibnn of porphyria. This takes place, for instance, in
heavy metal intoxications, especially with lead (3).
Other heavy metals like aluminium, mercury and cad-
mium do not produce Inhibition of porphobilinogen
synthase in concentrations that are toxic in vivo (5).
High levels of lead displace zinc from the porphobi-
linogen synthase, generating an intense Inhibition of
enzymatic activity, with an accumulation of the sub-
strate 5-aminolaevulinic acid, which then increases in
the urine. Therefore, to confirm the diagnosis of he-
reditary porphobilinogen synthase deficiency, it is nec-
essary to rule out lead intoxication.
This work describes the confirmation, by laboratory
means, of porphobilinogen synthase deficiency in two
brothers from a rural zone who presented with clinical
manifestations compatible with a porphyric acute cri-
sis.
Patients Description
Two brothers (aged 26 and 28 years), Farmers from Lumaco, a
village located 750 kilometers south of Santiago, presented with
similar Symptoms within 10 days of each other: arterial hyper-
tension, tachycardia, severe constipation and intense colic pain
in the lower abdominal region, which did not respond to an^
tispasmodic drugs. They had no fever or anaemia, and the urine
Sediment was normal. They were not alcoholics or carriers of
any chronic diseases. Intestinal obstruction, salmonellosis, and
other infectious diseases were ruled out. There was no clinical
evidence of tyrosinaemia, diabetes or renal insufficiency. They
were neither taking any kind of drugs nor were they fasting.
Neither patient showed any cutaneous lesions during the clinical
course of their disease.
The casual observation that the urine turned dark when it was
exposed to light, led us to consider the possibility of an acute
crisis of porphyria.
Methods
Levels of porphobilinogen (10), 5-aminolaevulinic acid (11)
coproporphyrin and uroporphyrin (12) were determined in ur-
ine samples. Coproporphyrin and protoporphyrin (12) were
determined in faecal samples. Blood levels of erythrocyte pro-
toporphyrin (13) and the enzymatic activity of porphobilinogen
synthase (5) were evaluated in the presence of dithiothreitol, 10
mmol/1, to eliminate any possible action of lead on porphobi-
linogen synthase activity (14). Enzyme activity was evaluated
with and without zinc Chloride 0.1 mmol/1. Serum levels of lead
were measured by electrothermal atomic absorption spectros-
copy (15).
Results
Determinations of the level of both porphyrins and
their precursors in urine, faeces and blood (tab. l, Ist
evaluations) showed a typical pattern of lead intoxi-
cation. Nevertheless, a thorough search for a possible
lead contact proved negative.
In a second laboratory check-up a few months later,
the patients were asymptomatic (tab. l, 2nd evalua-
tion) showing a blood lead level within permissible
limits and erythrocyte porphobilinogen synthase ac-
tivity significantly decreased when compared with
normal healthy control subjects. No n rmalization of
activity was observed when the enzyme activity was
determined in the presence of dithiothreitol or di-
thiothreitol plus zinc ions.
••'i;6;
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Tab. 1. Laboratory results in both patients (A and B) on two occasions, Ist evaluation during acute crisis and 2nd evaluation
while asymptomatic.
Reference
values
Ist evaluation
Patient
A B~
2nd evaluation
Patient
Urine sample
5-Aminolaevulinate
Porphobilinogen
Coproporphyrin
Uroporphyrin
μτηοΐ/day
μηιοΐ/day
nmol/day
nmol/day
12.5-52.3
Up to 5,3
Up to 228
Upto 21
397.1
15.0
4101
NP
370.1
17.2
2660
ND
ND = Not detected
* reaction wilh 10 mmol/l dithiothreitol
** reaction with 0.1 mmol/1 zinc chloride
42.0
5.7
398
42
61.5
6.2
184
46
Stool sample
Coproporphyrin
Protoporphyrin
Blood sample
Protoporphyrins
Porphobilinogen synthase*
Porphobilinogen synthase**
Lead
Red blood cells
nmol/g dry weight
nmol/g dry weight
μπιοΐ/ΐ erythrocytes
U/l erythrocytes
U/l erythrocytes
mmol/1
10I2/1
Up to
Up to
Up to
18-50
18-^50
Upto
4.5-5.
26
48
1.0
1.6
5
7.0
15.0
4.0
—
—
6.9
14.4
4.1
—
—
0.3
1.6
0.52
1.50
' 2,50 '
0.90
5.1
2.0
1.1
0.67
1.70
3.60
1.01
5.0
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Discussion
Acute hepatic porphyric syndrome linked to a por-
phobilinogen synthase deficiency was first reported
by Doss et al. (4) in two young patients who prescnted
with an activity of this enzyme below l % of the value
of normal control subjects. Since then, two other cases
have been dcscribed in the literature.
Normally, porphobilinogen synthase activity is in con-
siderable excess and for this reason it is not a rate
limiting slep. To influcnce haem biosynthesis, the In-
hibition must be more than 90%. This degree of
Inhibition is manifested clinically (8), and it is found
only in patients who are homozygous for the defect
(l 6); the two brothers in the present study are homo-
zygotes. In heterozygous patients, the clinical and
biochemical evidence is slight or absent.
The low incidence of homozygous patients in spitc of
the fact that heterozygotes are not that rare could
reflect the fact that this condition is incompatible with
life and could be a cause of spontaneous abortion (1).
On the other hand, this disease is considered a rarity
by clinicians and is not thought of s a possible
diagnosis even when a patient has typical symptom-
atology. It should be kept in mind when other types
of porphyria or heavy metal intoxications are diag-
nosed.
This paper describes two new patients who are broth-
ers and who within a period of ten days presented
with an acute crisis similar to those observed in other
types of porphyria. The patients had arterial hyper-
tension, tachycardia, constipation, abdominal pain,
and a diagnostic sign of porphyria: blackening of the
urine when exposcd to sunlight.
The pattern of urine excretion and blood levels of
both porphyrins and their precursors were closely
similar to those found in lead poisoning. Allhough
the factor that triggered the crisis in our two patients
could not be identified, it is clear that lead was not
involved, because blood levels were normal, and there
was no normalization of porphobilinogen synthase
activity when dithiothreitol was added to the enzyme
assay medium. Moreover, the activity of this enzyme
did not reach normal levels when zinc ions were added
to the final assay (14). As in our cases, a triggering
factor could not be identified in the three adult pa-
tients reported in the literature.
The fact that these two patients are brothers and have
similar life styles, and they simultaneously presented
with an acute crisis, strongly suggests that a genetic
defect was expressed by a common triggering factor.
In both patients, clinical manifestation subsided spon-
taneously without specific treatment.
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